Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Public ClinicalTrials.gov record NCT01416441. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Study identification
- NCT ID
- NCT01416441
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Industry
- Enrollment
- 170 participants
Conditions and interventions
Conditions
Interventions
- Aripiprazole Drug
Drug
Eligibility (public fields only)
- Age range
- 7 Years to 18 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 18, 2011
- Primary completion
- Mar 12, 2014
- Completion
- Mar 12, 2014
- Last update posted
- Oct 6, 2021
2011 – 2014
United States locations
- U.S. sites
- 36
- U.S. states
- 20
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Dothan | Alabama | 36303 | — |
| Not listed | Little Rock | Arkansas | 72205 | — |
| Not listed | Los Angeles | California | 90095 | — |
| Not listed | Sacramento | California | 95815 | — |
| Not listed | San Diego | California | 92108 | — |
| Not listed | San Francisco | California | 94143 | — |
| Not listed | Santa Ana | California | 92701 | — |
| Not listed | Wildomar | California | 92595 | — |
| Not listed | Gainesville | Florida | 32610 | — |
| Not listed | Hialeah | Florida | 33012 | — |
| Not listed | Miami | Florida | 33126 | — |
| Not listed | Orange City | Florida | 32763 | — |
| Not listed | St. Petersburg | Florida | 33701 | — |
| Not listed | Atlanta | Georgia | 30308 | — |
| Not listed | Atlanta | Georgia | 30329 | — |
| Not listed | Chicago | Illinois | 60612 | — |
| Not listed | Indianapolis | Indiana | 46202-5200 | — |
| Not listed | Overland Park | Kansas | 66211 | — |
| Not listed | New Orleans | Louisiana | 70114 | — |
| Not listed | Bloomfield Hills | Michigan | 48302 | — |
| Not listed | Omaha | Nebraska | 68131 | — |
| Not listed | Manhasset | New York | 11030 | — |
| Not listed | Staten Island | New York | 10312 | — |
| Not listed | Avon Lake | Ohio | 44012 | — |
| Not listed | Cincinnati | Ohio | 45229-3039 | — |
| Not listed | Cleveland | Ohio | 44106 | — |
| Not listed | Middleburg Heights | Ohio | 44130 | — |
| Not listed | Oklahoma City | Oklahoma | 73112 | — |
| Not listed | Philadelphia | Pennsylvania | 19139 | — |
| Not listed | Dallas | Texas | 75230 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | San Antonio | Texas | 78258 | — |
| Not listed | Salt Lake City | Utah | 84106 | — |
| Not listed | Charlottesville | Virginia | 22903 | — |
| Not listed | Bothell | Washington | 98011 | — |
| Not listed | La Crosse | Wisconsin | 54601 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01416441, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 6, 2021 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01416441 live on ClinicalTrials.gov.